Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of Influenza Vaccine Safety Study in Asthmatic Children
NCT02967393Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2016
- Primary completion
- Feb 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of Fluzone Trivalent in influenza (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Number of Parents That Complete the Memory Aid 1 at 15 days, Number of Parent Completing Collection of Adverse Event Data and 9 more. Started Oct 2016; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02967393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967393.